ADMET analysis of phyto-components of Syzygium cumini seeds and Allium cepa peels

被引:7
|
作者
Kadri, Heena S. [1 ]
Minocheherhomji, Farida P. [1 ]
机构
[1] BP Baria Sci Inst, Microbiol Dept, Nasari, Gujarat, India
关键词
Pharmacokinetics; Drug-likeness; Toxicology; Syzygium cumini; Allium cepa; Gas chromatography mass spectrometry; DruLiTo; VEGA QSAR; ANTIOXIDANT;
D O I
10.1186/s43094-020-00136-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The inedible wastes generated from vegetables and fruits are one of the sources of environmental pollution if not utilized or disposed-off in a proper way. Research is focused on the utilization of these wastes as potential resources rather than undesirable and unwanted products in order to avoid contamination of natural resources. Syzygium cumini (black plum) seeds and Allium cepa (onion) peels were studied. These wastes were fermented and phyto-components of these wastes were determined by gas chromatography mass spectrometry (GCMS). The phyto-components were examined for their pharmacokinetics properties like drug-likeness and toxicity. The open source softwares, DruLiTo and VEGA QSAR, were used to perform the aforementioned study. Result GCMS: Twenty phyto-components were identified by performing GCMS analysis of the methanol extracts of fermented Syzygium cumini seeds and fermented Allium cepa peels. DruLiTo: Four phyto-components each from the methanol extracts of Syzygium cumini seeds and Allium cepa peels followed all the drug-likeness rules. VEGA QSAR: Six phyto-components of methanol extract of fermented Syzygium cumini seeds were identified as non-mutagenic whereas nine phyto-components of methanol extract of fermented Allium cepa peels were non-mutagenic. Collectively two phyto-components of methanol extracts of Syzygium cumini seeds and four phyto-components of methanol extracts of Allium cepa possess the pharmacokinetic properties. Conclusion: The phyto-components predicted to be drug-like and non-mutagenic can be further studied as ligands for bacterial and cancerous targets by the means of in-silico docking approach/techniques. The exploration carries supportive data for future examinations that can lead to their therapeutic use.
引用
收藏
页数:9
相关论文
共 7 条
  • [1] ADMET analysis of phyto-components of Syzygium cumini seeds and Allium cepa peels
    Heena S. Kadri
    Farida P. Minocheherhomji
    Future Journal of Pharmaceutical Sciences, 6
  • [2] Neutral components in the leaves and seeds of Syzygium cumini
    Kumar, A.
    Jayachandran, T.
    Aravindhan, P.
    Deecaraman, D.
    Ilavarasan, R.
    Padmanabhan, N.
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 3 (11): : 560 - 561
  • [3] Ultrafiltration of Syzygium cumini (L.) seeds extract: Analysis of flux decline and extract stability
    Balyan, Upasna
    Sarkar, Biswajit
    ASIA-PACIFIC JOURNAL OF CHEMICAL ENGINEERING, 2018, 13 (02)
  • [4] Chromatographic analysis and antiproliferative potential of aqueous extracts of Punica granatum fruit peels using the Allium cepa test
    Kuhn, Andrielle Wouters
    Tedesco, Marilia
    Boligon, Aline Augusti
    Athayde, Margareth Linde
    Laughinghouse, Haywood Dail
    Tedesco, Solange Bosio
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 51 (01) : 241 - 248
  • [5] Effect of media components on the gynogenic regeneration of onion (Allium cepa L) cultivars and analysis of regenerants
    Jakse, M
    Bohanec, B
    Ihan, A
    PLANT CELL REPORTS, 1996, 15 (12) : 934 - 938
  • [6] A comparative analysis of phyto-components on EGFR binding, viability, and migration in HPV positive ME180 and HPV negative C33A cervical cancer cells
    Rajalakshmi Sabanayagam
    Sneha Krishnamoorthy
    Mohan Anbuselvam
    Bharathi Muruganantham
    Sridhar Muthusami
    Medical Oncology, 40
  • [7] A comparative analysis of phyto-components on EGFR binding, viability, and migration in HPV positive ME180 and HPV negative C33A cervical cancer cells
    Sabanayagam, Rajalakshmi
    Krishnamoorthy, Sneha
    Anbuselvam, Mohan
    Muruganantham, Bharathi
    Muthusami, Sridhar
    MEDICAL ONCOLOGY, 2023, 40 (12)